OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial
Nicholas Russell, Rudolf Hoermann, Ada S. Cheung, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 5, pp. 617-627
Closed Access | Times Cited: 6
Nicholas Russell, Rudolf Hoermann, Ada S. Cheung, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 5, pp. 617-627
Closed Access | Times Cited: 6
Showing 6 citing articles:
The loss of estradiol by androgen deprivation in prostate cancer patients shows the importance of estrogens in males
Herjan J.T. Coelingh Bennink, Amanda Prowse, Jan F M Egberts, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 5
Herjan J.T. Coelingh Bennink, Amanda Prowse, Jan F M Egberts, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 5
Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood
Allison B. Reiss, Shelly Gulkarov, Aaron Pinkhasov, et al.
Medicina (2023) Vol. 60, Iss. 1, pp. 77-77
Open Access | Times Cited: 4
Allison B. Reiss, Shelly Gulkarov, Aaron Pinkhasov, et al.
Medicina (2023) Vol. 60, Iss. 1, pp. 77-77
Open Access | Times Cited: 4
Prostate Specific Antigen and Prostate Cancer in Gender Affirming Hormone Therapy for Transgender or Nonbinary Individuals
Kylie Morgan, Leah N. Deshler, M.D. Tibbs, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 121, Iss. 3, pp. 761-767
Closed Access | Times Cited: 1
Kylie Morgan, Leah N. Deshler, M.D. Tibbs, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 121, Iss. 3, pp. 761-767
Closed Access | Times Cited: 1
The effect of estradiol add-back: a longitudinal MRI study in prostate cancer patients
Orwa Dandash, James Allebone, Adam G. Mirabelli, et al.
Endocrine Connections (2024) Vol. 13, Iss. 3
Open Access
Orwa Dandash, James Allebone, Adam G. Mirabelli, et al.
Endocrine Connections (2024) Vol. 13, Iss. 3
Open Access
Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?
Kirby R. Qin, E. Mertens, Jake Tempo, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 5, pp. 920-922
Open Access
Kirby R. Qin, E. Mertens, Jake Tempo, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 5, pp. 920-922
Open Access
Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study
Yazid Belkacémi, G. Coraggio, Anne Brunel, et al.
Advances in Radiation Oncology (2023) Vol. 8, Iss. 5, pp. 101255-101255
Open Access | Times Cited: 1
Yazid Belkacémi, G. Coraggio, Anne Brunel, et al.
Advances in Radiation Oncology (2023) Vol. 8, Iss. 5, pp. 101255-101255
Open Access | Times Cited: 1
